相关实验视频

Updated: Jan 15, 2026

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

Published on: February 5, 2018

阿尔茨海默病中的星细胞反应:好还是坏?

Alaa Ismail¹, Hayder M Al-Kuraishy², Ali I Al-Gareeb³

¹Microbiology Department, Medicine College, Taif University, Taif, Kingdom of Saudi Arabia.

|October 8, 2025

概括

阿尔茨海默病 (AD) 涉及粉样β和团,影响像星体细胞这样的大脑支持细胞. 本综述阐明了星形细胞在阿尔茨海默病发病过程中的双重作用,无论是保护性的还是有害的.

科学领域:

神经科学是一个神经科学.
神经退行性疾病神经退行性疾病
细胞生物学细胞生物学

背景情况:

阿尔茨海默病 (AD) 是与年龄相关的神经退行的主要原因.
阿尔茨海默病的发病包括粉样β (Aβ) 斑块和神经纤维状结 (NFT).
这些病理影响神经元功能和支持质细胞,包括星球细胞.

研究的目的:

阐明星体细胞在阿尔茨海默氏病中的复杂而往往矛盾的作用.
审查神经细胞激活影响AD进展的机制.
讨论在AD的背景下,星球细胞主要是保护性的还是有害的.

主要方法:

关于AD中天体细胞生物学现有文献的小型综述.
分析研究的研究,调查星球细胞激活在对AD病理的反应.
关于神经退行症中星病的功能结果的证据综合.

主要成果:

星球细胞激活是对AD相关压力因素的常见反应,如氧化应激和炎症.
激活的星球细胞可以表现出神经保护和神经毒性功能.
天体细胞对阿尔茨海默氏病进展的确切影响仍然不完全理解.

结论:

星球细胞在阿尔茨海默病中发挥着多方面的作用.
了解星体细胞的行为对于开发有效的AD疗法至关重要.
需要进一步的研究,以充分界定向AD中的星球细胞的治疗潜力.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.粉样蛋白β是什么粉样蛋白β是什么星球细胞是星球细胞.陶氏蛋白质是一种陶氏蛋白质.

更多相关视频

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein

Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein

Published on: July 29, 2018

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...